06524347 is referenced by 181 patents and cites 13 patents.

This invention is directed to quinoline/quinoxaline compounds which inhibit platelet-derived growth factor tyrosine kinase and/or Lck tyrosine kinase, to pharmaceutical compositions comprising these compounds, and to the use of these compounds for treating a patient suffering from or subject to disorders/conditions involving cellular differentiation, proliferation, extracellular matrix production or mediator release and/or T cell activation and proliferation.

Title
Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
Application Number
9/675741
Publication Number
6524347 (B1)
Application Date
September 29, 2000
Publication Date
February 25, 2003
Inventor
Martin P Maguire
Woburn
MA, US
Paul E Persons
Westborough
MA, US
Alfred P Spada
Lansdale
PA, US
Michael R Myers
Reading
PA, US
Agent
Raymond S Parker III
US
Peter J Butch
US
Assignee
Avantis Pharmaceuticals
NJ, US
IPC
A61K 31/498
View Original Source